Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Apr 1;6(3):223-232.
doi: 10.1002/ams2.411. eCollection 2019 Jul.

Diagnosis of sepsis-induced disseminated intravascular coagulation and coagulopathy

Toshiaki Iba  1 , Yutaka Umemura  2 , Eizo Watanabe  3   4 , Takeshi Wada  5 , Kei Hayashida  6 , Shigeki Kushimoto  7 ; Japanese Surviving Sepsis Campaign Guideline Working Group for disseminated intravascular coagulation
Affiliations
Review

Diagnosis of sepsis-induced disseminated intravascular coagulation and coagulopathy

Toshiaki Iba et al. Acute Med Surg. .

Abstract

Disseminated intravascular coagulation (DIC) is a frequent complication in sepsis. Once patients develop DIC, the mortality rate increases significantly. Moreover, recent studies have suggested that coagulation disorder plays a significant role in the development of organ dysfunction in sepsis. Thus, the early detection of DIC is vital in sepsis care, and the Japanese Association for Acute Medicine established a set of original diagnostic criteria in 2006 (JAAM DIC). Since then, the usefulness of the JAAM DIC has been repeatedly reported, and these criteria have been widely adopted in emergency and critical care settings in Japan. Different criteria have also been released by the International Society on Thrombosis and Haemostasis (ISTH overt-DIC), and the latter criteria are presently considered to be the international standard. Compared with the JAAM DIC, the ISTH overt-DIC criteria are stricter and the timing of diagnosis is later. This discrepancy is because of conceptual differences. As many physicians think sepsis-associated DIC is the target of anticoagulant therapies in Japan, the JAAM DIC criteria were designed to allow the early initiation of treatment. As other countries do not provide DIC-specific treatments, early diagnosis is not necessary, and this situation has led to a significant gap. However, as overt-DIC is a late-phase coagulation disorder, a need for early detection has been advocated, and members of the ISTH have recently proposed the category of sepsis-induced coagulopathy. In this review, we introduce the strengths and weaknesses of the major criteria including JAAM-DIC, ISTH overt-DIC, sepsis-induced coagulopathy, and Japanese Society on Thrombosis and Haemostasis-DIC.

Keywords: Coagulopathy; diagnostic criteria; disseminated intravascular coagulation; sepsis/multiple organ failure.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The intention for the diagnostic criteria for disseminated intravascular coagulation (DIC) and coagulopathy in sepsis in terms of validity versus simplicity. ISTH, International Society on Thrombosis and Haemostasis; JAAM, Japanese Association for Acute Medicine; JMHW, Japanese Ministry of Health and Welfare; JSTH, Japanese Society on Thrombosis and Hemostasis; SIC, sepsis‐induced coagulopathy.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

  • Why is DIC a Rare Diagnosis in the 21st Century?
    Thachil J, Iba T, Scarlatescu E, Levy JH. Thachil J, et al. Juntendo Iji Zasshi. 2024 Mar 28;70(2):121-124. doi: 10.14789/jmj.JMJ24-0005-P. eCollection 2024. Juntendo Iji Zasshi. 2024. PMID: 39430207 Free PMC article.
  • [Disseminated intravascular coagulation: role of the International Society on Thrombosis and Haemostasis (ISTH) diagnostic scoring system].
    Bouzidi S, Daiki M, Nasr AA, Nsiri K, Layouni S, Hajjej Z, Fekih-Mrissa N, Ferjani M, Nsiri B. Bouzidi S, et al. Pan Afr Med J. 2020 Jul 6;36:154. doi: 10.11604/pamj.2020.36.154.20368. eCollection 2020. Pan Afr Med J. 2020. PMID: 32874418 Free PMC article. French.
  • Age-related differences in the survival benefit of the administration of antithrombin, recombinant human thrombomodulin, or their combination in sepsis.
    Wada T, Yamakawa K, Kabata D, Abe T, Ogura H, Shiraishi A, Saitoh D, Kushimoto S, Fujishima S, Mayumi T, Hifumi T, Shiino Y, Nakada TA, Tarui T, Otomo Y, Okamoto K, Umemura Y, Kotani J, Sakamoto Y, Sasaki J, Shiraishi SI, Takuma K, Tsuruta R, Hagiwara A, Masuno T, Takeyama N, Yamashita N, Ikeda H, Ueyama M, Fujimi S, Gando S. Wada T, et al. Sci Rep. 2022 Jun 3;12(1):9304. doi: 10.1038/s41598-022-13346-3. Sci Rep. 2022. PMID: 35660774 Free PMC article.
  • The pathophysiology, diagnosis, and management of sepsis-associated disseminated intravascular coagulation.
    Iba T, Helms J, Connors JM, Levy JH. Iba T, et al. J Intensive Care. 2023 May 23;11(1):24. doi: 10.1186/s40560-023-00672-5. J Intensive Care. 2023. PMID: 37221630 Free PMC article. Review.
  • The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020).
    Egi M, Ogura H, Yatabe T, Atagi K, Inoue S, Iba T, Kakihana Y, Kawasaki T, Kushimoto S, Kuroda Y, Kotani J, Shime N, Taniguchi T, Tsuruta R, Doi K, Doi M, Nakada TA, Nakane M, Fujishima S, Hosokawa N, Masuda Y, Matsushima A, Matsuda N, Yamakawa K, Hara Y, Sakuraya M, Ohshimo S, Aoki Y, Inada M, Umemura Y, Kawai Y, Kondo Y, Saito H, Taito S, Takeda C, Terayama T, Tohira H, Hashimoto H, Hayashida K, Hifumi T, Hirose T, Fukuda T, Fujii T, Miura S, Yasuda H, Abe T, Andoh K, Iida Y, Ishihara T, Ide K, Ito K, Ito Y, Inata Y, Utsunomiya A, Unoki T, Endo K, Ouchi A, Ozaki M, Ono S, Katsura M, Kawaguchi A, Kawamura Y, Kudo D, Kubo K, Kurahashi K, Sakuramoto H, Shimoyama A, Suzuki T, Sekine S, Sekino M, Takahashi N, Takahashi S, Takahashi H, Tagami T, Tajima G, Tatsumi H, Tani M, Tsuchiya A, Tsutsumi Y, Naito T, Nagae M, Nagasawa I, Nakamura K, Nishimura T, Nunomiya S, Norisue Y, Hashimoto S, Hasegawa D, Hatakeyama J, Hara N, Higashibeppu N, Furushima N, Furusono H, Matsuishi Y, Matsuyama T, Minematsu Y, Miyashita R, Miyatake Y, Moriyasu M, Yamada T, Yamada H, Yamamoto R, Yoshida T, Yoshida Y, Yoshimura J, Yotsumoto R, Yonekura H, Wada T, Watanabe E, Aoki M, Asai H, Abe T, Igarashi Y, Iguch… See abstract for full author list ➔ Egi M, et al. J Intensive Care. 2021 Aug 25;9(1):53. doi: 10.1186/s40560-021-00555-7. J Intensive Care. 2021. PMID: 34433491 Free PMC article.
See all "Cited by" articles

References

    1. Taylor FB, Toh CH, Hoots WK, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb. Haemost. 2001; 86: 1327–30. - PubMed
    1. Kobayashi N, Maekawa T, Takada M, Tanaka H, Gonmori H. Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan. Bibl. Haematol. 1983; 49: 265–75. - PubMed
    1. Toh CH, Hoots WK. The scoring system of the scientific and standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: a 5‐year overview. J. Thromb. Haemost. 2007; 5: 604–6. - PubMed
    1. Gando S, Levi M, Toh CH. Disseminated intravascular coagulation. Nat. Rev. Dis. Primers 2016; 2: 16037. - PubMed
    1. Gando S, Iba T, Eguchi Y et al A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Crit. Care Med. 2006; 34: 625–31. - PubMed